Delivery Order 75N91019D00024-75N91021F00002
Award Date 2/9/21
Potential Completion Date 11/13/25
Potential Value $6.3M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI) awarded a delivery order contract to Leidos Biomedical Research Inc., a Federally Funded Research and Development Center (FFRDC) contractor and subsidiary of Leidos Holdings, Inc., on September 27, 2023. This cost-plus-fixed-fee delivery order, valued at $1.78 million with an ultimate completion date of October 7, 2025, supports facilities and cost efficiency initiatives aligned with the President's Department of Government Efficiency objectives announced in...
- This is a $15,990,578.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for coordinated facilities requirements and support services for the NCI through September 2030. This contract is not set aside for any specific business category. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for facility leases and operational task orders for the NCI's Federally Funded Research and Development Center (FFRDC) over fiscal years 2024 and 2025, with a total potential value of $27,119,138.00. The contract does not have a set-aside designation, indicating Leidos Biomedical Research Inc. was...
- This is a $20,958,316.78 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for a Federally Funded Research and Development Center (FFRDC) to support the NCI's facilities and implement the President's Department of Government Efficiency Cost Efficiency Initiative. The contract has an ultimate completion date of August 29, 2025 and was awarded on September 28, 2019....
- This is a $2,528,739 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is part of the NCI's Cancer Data Ecosystem program and has an ultimate completion date of April 30, 2026. The contract does not have a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a wide range of...
- This is a $163,472,364.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract has an ultimate completion date of September 29, 2028 and does not utilize a set-aside designation. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing comprehensive biomedical research and facilities support services....
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a cost-plus-fixed-fee delivery order contract worth up to $3,332,886.00 to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for the identification and delivery of clinical drug candidates, with a completion date of September 24, 2025. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) that provides...
- This is a $401,797,653 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for operational task order work with an ultimate completion date of August 30, 2025. Leidos Biomedical Research Inc. is an experienced Federally Funded Research and Development Center (FFRDC) contractor for NCI, providing comprehensive biomedical research and facilities support services. The...
- This is a $4,686,999.20 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is to support the President's Department of Government Efficiency Cost Efficiency Initiative through a Phase 1 trial, with a period of performance ending on July 6, 2026. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing...
- This is a $35,180,631.00 FFRDC task order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for a wide range of biomedical research and facilities support services, with a period of performance through August 30, 2026. The contract is a cost-plus-fixed-fee delivery order and does not have a set-aside designation. Key subcontractors include Franklin Young International, Inc., a Service-Disabled...